New Zealand markets closed

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
585.68-1.72 (-0.29%)
At close: 04:05PM EST
595.00 +9.32 (+1.59%)
After hours: 07:13PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 22.34B
Enterprise value 21.23B
Trailing P/E 3.38
Forward P/E 49.02
PEG ratio (5-yr expected) 3.52
Price/sales (ttm)7.56
Price/book (mrq)1.46
Enterprise value/revenue 7.12
Enterprise value/EBITDA 2.44

Trading information

Stock price history

Beta (5Y monthly) 0.86
52-week change 3-0.45%
S&P500 52-week change 314.07%
52-week high 3832.70
52-week low 3545.00
50-day moving average 3722.86
200-day moving average 3701.94

Share statistics

Avg vol (3-month) 3126.76k
Avg vol (10-day) 3179.56k
Shares outstanding 524.84M
Implied shares outstanding 629.92M
Float 821.45M
% held by insiders 114.22%
% held by institutions 179.94%
Shares short (30 Dec 2021) 4301.42k
Short ratio (30 Dec 2021) 42.36
Short % of float (30 Dec 2021) 41.42%
Short % of shares outstanding (30 Dec 2021) 41.01%
Shares short (prior month 29 Nov 2021) 4376.62k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 307 Mar 2002

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 223.47%
Operating margin (ttm)20.89%

Management effectiveness

Return on assets (ttm)2.43%
Return on equity (ttm)55.13%

Income statement

Revenue (ttm)2.98B
Revenue per share (ttm)99.96
Quarterly revenue growth (yoy)15.40%
Gross profit (ttm)1.44B
EBITDA 758.89M
Net income avi to common (ttm)6.66B
Diluted EPS (ttm)220.48
Quarterly earnings growth (yoy)198.70%

Balance sheet

Total cash (mrq)1.34B
Total cash per share (mrq)44.69
Total debt (mrq)225.26M
Total debt/equity (mrq)1.47
Current ratio (mrq)3.80
Book value per share (mrq)512.48

Cash flow statement

Operating cash flow (ttm)783.33M
Levered free cash flow (ttm)622.38M